medroxyprogesterone acetate has been researched along with Choriocarcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lumbers, ER; Pringle, KG; Wang, Y | 1 |
Auchus, RJ; Lee, TC; Miller, WL | 1 |
2 other study(ies) available for medroxyprogesterone acetate and Choriocarcinoma
Article | Year |
---|---|
The effects of cyclic AMP, sex steroids and global hypomethylation on the expression of genes controlling the activity of the renin-angiotensin system in placental cell lines.
Topics: Adult; Azacitidine; Cell Line, Tumor; Choriocarcinoma; Cyclic AMP; DNA Methylation; Drug Therapy, Combination; Estradiol; Female; Gene Expression Regulation, Developmental; Gene Silencing; Humans; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Trimester, First; Renin-Angiotensin System; Trophoblasts | 2013 |
Medroxyprogesterone acetate and dexamethasone are competitive inhibitors of different human steroidogenic enzymes.
Topics: Animals; Anti-Inflammatory Agents; Binding, Competitive; Cholesterol Side-Chain Cleavage Enzyme; Choriocarcinoma; Dexamethasone; Enzyme Inhibitors; Humans; Kinetics; Medroxyprogesterone Acetate; Microsomes; Multienzyme Complexes; Pregnenolone; Progesterone Reductase; Radioimmunoassay; Rats; Steroid 17-alpha-Hydroxylase; Steroid Isomerases; Steroids; Tumor Cells, Cultured; Yeasts | 1999 |